Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gluconeogenesis | 14 | 2024 | 111 | 2.320 |
Why?
|
| Insulin Resistance | 16 | 2023 | 698 | 1.530 |
Why?
|
| Glucose | 17 | 2024 | 914 | 1.360 |
Why?
|
| Lipodystrophy | 4 | 2023 | 34 | 0.580 |
Why?
|
| Energy Metabolism | 4 | 2024 | 813 | 0.560 |
Why?
|
| Insulin | 11 | 2023 | 1225 | 0.550 |
Why?
|
| Glycogenolysis | 3 | 2018 | 10 | 0.540 |
Why?
|
| Blood Glucose | 16 | 2024 | 1169 | 0.490 |
Why?
|
| Parenteral Nutrition, Total | 3 | 2011 | 113 | 0.480 |
Why?
|
| Bile Acids and Salts | 4 | 2022 | 258 | 0.470 |
Why?
|
| Parenteral Nutrition | 6 | 2022 | 199 | 0.460 |
Why?
|
| Infant, Premature | 4 | 2023 | 856 | 0.420 |
Why?
|
| Digestion | 3 | 2020 | 45 | 0.400 |
Why?
|
| Fat Emulsions, Intravenous | 4 | 2021 | 78 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2024 | 1413 | 0.380 |
Why?
|
| Hyperglycemia | 4 | 2018 | 239 | 0.380 |
Why?
|
| Ghrelin | 1 | 2012 | 55 | 0.370 |
Why?
|
| Glycine | 4 | 2024 | 172 | 0.370 |
Why?
|
| Bariatric Surgery | 2 | 2024 | 142 | 0.350 |
Why?
|
| Metformin | 2 | 2024 | 165 | 0.330 |
Why?
|
| Cholestasis | 3 | 2021 | 157 | 0.330 |
Why?
|
| Deuterium Oxide | 2 | 2020 | 17 | 0.330 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2020 | 82 | 0.310 |
Why?
|
| Fasting | 4 | 2022 | 309 | 0.310 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2010 | 200 | 0.300 |
Why?
|
| Methionine | 4 | 2011 | 105 | 0.300 |
Why?
|
| Fatty Acids | 3 | 2020 | 367 | 0.300 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 214 | 0.300 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 85 | 0.290 |
Why?
|
| Starch | 3 | 2020 | 28 | 0.280 |
Why?
|
| Liver Diseases | 3 | 2019 | 386 | 0.280 |
Why?
|
| Premature Birth | 3 | 2022 | 417 | 0.280 |
Why?
|
| alpha-Glucosidases | 2 | 2020 | 31 | 0.270 |
Why?
|
| Vitamin E | 2 | 2019 | 66 | 0.270 |
Why?
|
| Liver | 6 | 2021 | 1850 | 0.260 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 387 | 0.250 |
Why?
|
| Soybean Oil | 4 | 2021 | 71 | 0.250 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2017 | 19 | 0.240 |
Why?
|
| Carbon Isotopes | 5 | 2020 | 277 | 0.240 |
Why?
|
| Animals, Newborn | 6 | 2023 | 1028 | 0.230 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2024 | 13 | 0.220 |
Why?
|
| Benzoic Acid | 1 | 2024 | 3 | 0.220 |
Why?
|
| Dietary Carbohydrates | 2 | 2016 | 118 | 0.220 |
Why?
|
| Thermogenesis | 1 | 2024 | 52 | 0.220 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 87 | 0.210 |
Why?
|
| Enteral Nutrition | 3 | 2023 | 269 | 0.210 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 93 | 0.210 |
Why?
|
| Phytosterols | 2 | 2021 | 28 | 0.200 |
Why?
|
| Swine | 6 | 2023 | 1190 | 0.200 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2022 | 5 | 0.200 |
Why?
|
| Leptin | 2 | 2023 | 222 | 0.200 |
Why?
|
| Glutathione | 3 | 2021 | 198 | 0.190 |
Why?
|
| Hypoglycemic Agents | 3 | 2024 | 481 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4817 | 0.190 |
Why?
|
| Adipose Tissue | 3 | 2020 | 510 | 0.190 |
Why?
|
| Sus scrofa | 4 | 2019 | 123 | 0.180 |
Why?
|
| Animals | 21 | 2024 | 35889 | 0.180 |
Why?
|
| Exercise | 2 | 2019 | 867 | 0.180 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 76 | 0.170 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2020 | 74 | 0.170 |
Why?
|
| Aging | 3 | 2024 | 1272 | 0.170 |
Why?
|
| Muscle Strength | 1 | 2021 | 86 | 0.170 |
Why?
|
| Incretins | 1 | 2020 | 24 | 0.170 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2018 | 138 | 0.170 |
Why?
|
| Acetylcysteine | 1 | 2021 | 84 | 0.170 |
Why?
|
| Receptor, Insulin | 1 | 2020 | 69 | 0.160 |
Why?
|
| Lipolysis | 1 | 2020 | 83 | 0.160 |
Why?
|
| Lipogenesis | 1 | 2020 | 59 | 0.160 |
Why?
|
| Oxidation-Reduction | 6 | 2020 | 460 | 0.160 |
Why?
|
| Male | 24 | 2024 | 65305 | 0.160 |
Why?
|
| Gastrectomy | 1 | 2020 | 102 | 0.160 |
Why?
|
| Homeostasis | 2 | 2021 | 745 | 0.160 |
Why?
|
| Barth Syndrome | 1 | 2019 | 1 | 0.160 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2010 | 84 | 0.150 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2011 | 177 | 0.150 |
Why?
|
| Phospholipids | 1 | 2019 | 107 | 0.150 |
Why?
|
| Humans | 34 | 2024 | 133017 | 0.150 |
Why?
|
| Rifampin | 1 | 2019 | 134 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 392 | 0.150 |
Why?
|
| Female | 25 | 2024 | 71342 | 0.150 |
Why?
|
| Alanine | 3 | 2023 | 183 | 0.150 |
Why?
|
| Fatty Liver | 1 | 2020 | 210 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2020 | 440 | 0.140 |
Why?
|
| Proglucagon | 1 | 2017 | 5 | 0.140 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2017 | 5 | 0.140 |
Why?
|
| Sucrase | 1 | 2017 | 22 | 0.140 |
Why?
|
| Glucagon | 3 | 2017 | 174 | 0.140 |
Why?
|
| Homocysteine | 4 | 2011 | 120 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2023 | 8531 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2021 | 484 | 0.140 |
Why?
|
| Isothiocyanates | 1 | 2017 | 11 | 0.140 |
Why?
|
| Intestines | 1 | 2021 | 613 | 0.140 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2017 | 39 | 0.130 |
Why?
|
| Gastrointestinal Agents | 1 | 2017 | 67 | 0.130 |
Why?
|
| Leucine | 3 | 2023 | 311 | 0.130 |
Why?
|
| Bicycling | 1 | 2016 | 36 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2021 | 803 | 0.120 |
Why?
|
| Cognition | 1 | 2021 | 813 | 0.120 |
Why?
|
| Thinness | 1 | 2016 | 77 | 0.120 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 52 | 0.120 |
Why?
|
| Adult | 14 | 2022 | 31725 | 0.120 |
Why?
|
| Models, Biological | 3 | 2016 | 1521 | 0.120 |
Why?
|
| Serine | 1 | 2016 | 171 | 0.110 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 82 | 0.110 |
Why?
|
| Inflammation | 2 | 2021 | 1543 | 0.110 |
Why?
|
| Microbiota | 1 | 2020 | 439 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 242 | 0.110 |
Why?
|
| Swine Diseases | 1 | 2014 | 42 | 0.110 |
Why?
|
| Mice | 8 | 2024 | 18886 | 0.100 |
Why?
|
| Calorimetry, Indirect | 3 | 2021 | 61 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 243 | 0.100 |
Why?
|
| Amino Acids | 3 | 2023 | 683 | 0.100 |
Why?
|
| Fish Oils | 3 | 2021 | 82 | 0.100 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2023 | 172 | 0.100 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 29 | 0.090 |
Why?
|
| Food Deprivation | 1 | 2012 | 34 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 673 | 0.090 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 5 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 93 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 45 | 0.090 |
Why?
|
| Muscle, Skeletal | 3 | 2023 | 1038 | 0.090 |
Why?
|
| Young Adult | 6 | 2021 | 9966 | 0.080 |
Why?
|
| Emulsions | 2 | 2021 | 70 | 0.080 |
Why?
|
| Gestational Age | 2 | 2015 | 1227 | 0.080 |
Why?
|
| Adolescent | 8 | 2024 | 20560 | 0.080 |
Why?
|
| Isotope Labeling | 3 | 2020 | 105 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2011 | 243 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2024 | 3429 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2015 | 552 | 0.080 |
Why?
|
| Colitis | 1 | 2011 | 172 | 0.080 |
Why?
|
| Amino Acids, Sulfur | 1 | 2009 | 15 | 0.080 |
Why?
|
| Craniosynostoses | 1 | 2011 | 134 | 0.080 |
Why?
|
| Abdomen | 1 | 2009 | 136 | 0.070 |
Why?
|
| Birth Weight | 1 | 2010 | 352 | 0.070 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2021 | 35 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 678 | 0.070 |
Why?
|
| Methenamine | 1 | 2008 | 7 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2013 | 814 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 469 | 0.070 |
Why?
|
| Lactation | 1 | 2009 | 199 | 0.070 |
Why?
|
| Body Water | 1 | 2008 | 90 | 0.070 |
Why?
|
| Glucose Tolerance Test | 2 | 2018 | 226 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2013 | 3977 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 3740 | 0.070 |
Why?
|
| Radioactive Tracers | 1 | 2006 | 22 | 0.060 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 48 | 0.060 |
Why?
|
| Obesity | 3 | 2024 | 2419 | 0.060 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2024 | 6 | 0.060 |
Why?
|
| Critical Illness | 1 | 2009 | 630 | 0.060 |
Why?
|
| Dioxoles | 1 | 2024 | 12 | 0.060 |
Why?
|
| Uncoupling Protein 1 | 1 | 2024 | 32 | 0.060 |
Why?
|
| Mitochondria | 2 | 2021 | 749 | 0.060 |
Why?
|
| Triglycerides | 2 | 2020 | 614 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 240 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2009 | 923 | 0.060 |
Why?
|
| Hippurates | 1 | 2024 | 6 | 0.050 |
Why?
|
| Liraglutide | 1 | 2024 | 15 | 0.050 |
Why?
|
| Pregnancy | 4 | 2021 | 7588 | 0.050 |
Why?
|
| Palmitates | 1 | 2023 | 19 | 0.050 |
Why?
|
| Biomarkers | 3 | 2021 | 3405 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1088 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2022 | 1714 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 3044 | 0.050 |
Why?
|
| Glycerol | 1 | 2023 | 99 | 0.050 |
Why?
|
| Child | 6 | 2021 | 25832 | 0.050 |
Why?
|
| Carbon | 1 | 2023 | 97 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2023 | 164 | 0.050 |
Why?
|
| Cholic Acid | 1 | 2022 | 20 | 0.050 |
Why?
|
| Diet | 3 | 2020 | 1169 | 0.050 |
Why?
|
| Glycine Agents | 1 | 2021 | 10 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2022 | 271 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2021 | 57 | 0.040 |
Why?
|
| Keto Acids | 1 | 2020 | 56 | 0.040 |
Why?
|
| Endothelium | 1 | 2021 | 70 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2012 | 329 | 0.040 |
Why?
|
| Peptide YY | 1 | 2020 | 19 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 163 | 0.040 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2020 | 20 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2012 | 569 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3123 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 450 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 29017 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 191 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 418 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 42 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 677 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 50 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 62 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2018 | 34 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 403 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 444 | 0.040 |
Why?
|
| Amino Acids, Essential | 1 | 2018 | 28 | 0.040 |
Why?
|
| Tritium | 2 | 2009 | 164 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2018 | 78 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 4847 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 259 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1314 | 0.040 |
Why?
|
| Gene Expression | 2 | 2014 | 1598 | 0.030 |
Why?
|
| Shrews | 1 | 2017 | 5 | 0.030 |
Why?
|
| DNA Damage | 1 | 2021 | 517 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2017 | 40 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2017 | 31 | 0.030 |
Why?
|
| Sulfoxides | 1 | 2017 | 10 | 0.030 |
Why?
|
| Methylation | 2 | 2009 | 232 | 0.030 |
Why?
|
| India | 1 | 2018 | 239 | 0.030 |
Why?
|
| Kinetics | 2 | 2009 | 1312 | 0.030 |
Why?
|
| China | 1 | 2018 | 293 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2018 | 200 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 436 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1461 | 0.030 |
Why?
|
| Glycogen | 1 | 2016 | 55 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 118 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 341 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2016 | 32 | 0.030 |
Why?
|
| Energy Intake | 1 | 2018 | 515 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 123 | 0.030 |
Why?
|
| Athletes | 1 | 2016 | 74 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 123 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 712 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 332 | 0.030 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2932 | 0.030 |
Why?
|
| Olive Oil | 1 | 2014 | 24 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 47 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 480 | 0.030 |
Why?
|
| Plant Oils | 1 | 2014 | 37 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2013 | 91 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1113 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6560 | 0.020 |
Why?
|
| Algorithms | 2 | 2009 | 1725 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 917 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5160 | 0.020 |
Why?
|
| Sex Factors | 1 | 2016 | 1355 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2830 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2503 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1109 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 14 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 16 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 15 | 0.020 |
Why?
|
| Infant | 3 | 2012 | 13143 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2011 | 50 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2013 | 317 | 0.020 |
Why?
|
| Peroxidase | 1 | 2011 | 65 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 562 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 188 | 0.020 |
Why?
|
| Hexoses | 1 | 2009 | 11 | 0.020 |
Why?
|
| Ketone Bodies | 1 | 2009 | 49 | 0.020 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2009 | 4 | 0.020 |
Why?
|
| Lactates | 1 | 2009 | 101 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 7165 | 0.020 |
Why?
|
| Nitrogen Isotopes | 1 | 2009 | 63 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1013 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2009 | 78 | 0.020 |
Why?
|
| C-Peptide | 1 | 2009 | 116 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1346 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4715 | 0.020 |
Why?
|
| Cysteine | 1 | 2009 | 143 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 285 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1124 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2009 | 107 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3121 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 457 | 0.020 |
Why?
|
| Cell Division | 1 | 2009 | 767 | 0.020 |
Why?
|
| Sulfur Compounds | 1 | 2007 | 4 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2007 | 14 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 471 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 2039 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 1018 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2006 | 39 | 0.020 |
Why?
|
| Capillaries | 1 | 2006 | 71 | 0.020 |
Why?
|
| Milk, Human | 1 | 2009 | 311 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 897 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 652 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2012 | 14844 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3864 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 3085 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21483 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6482 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12963 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 6314 | 0.010 |
Why?
|